PubRank

J Imperato-McGinley

Author PubWeight™ 54.79‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 The effect of finasteride in men with benign prostatic hyperplasia. The Finasteride Study Group. N Engl J Med 1992 7.16
2 Steroid 5alpha-reductase deficiency in man: an inherited form of male pseudohermaphroditism. Science 1974 3.00
3 Androgens and the evolution of male-gender identity among male pseudohermaphrodites with 5alpha-reductase deficiency. N Engl J Med 1979 1.66
4 Male pseudohermaphroditism due to steroid 5-alpha-reductase deficiency. Am J Med 1977 1.60
5 Long-term (7 to 8-year) experience with finasteride in men with benign prostatic hyperplasia. Urology 2002 1.58
6 Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest 1992 1.36
7 Male pseudohermaphroditism: the complexities of male phenotypic development. Am J Med 1976 1.26
8 Brief report: the molecular basis of steroid 5 alpha-reductase deficiency in a large Dominican kindred. N Engl J Med 1992 1.23
9 Male pseudohermaphroditism secondary to 5 alpha-reductase deficiency--a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem 1979 1.22
10 Reversibility of catecholamine-induced dilated cardiomyopathy in a child with a pheochromocytoma. N Engl J Med 1987 1.20
11 Clinical dose ranging studies with finasteride, a type 2 5alpha-reductase inhibitor, in men with male pattern hair loss. J Am Acad Dermatol 1999 1.18
12 Genetic and pharmacological evidence for more than one human steroid 5 alpha-reductase. J Clin Invest 1992 1.15
13 Familial male pseudohermaphroditism due to 5-alpha-reductase deficiency in a Turkish village. Am J Med 1986 1.04
14 Hormonal evaluation of a large kindred with complete androgen insensitivity: evidence for secondary 5 alpha-reductase deficiency. J Clin Endocrinol Metab 1982 0.99
15 Effects of flutamide and finasteride on rat testicular descent. Endocrinology 1991 0.97
16 Male pseudohermaphroditism due to multiple defects in steroid-biosynthetic microsomal mixed-function oxidases. A new variant of congenital adrenal hyperplasia. N Engl J Med 1985 0.96
17 Dihydrotestosterone regulation of semen in male pseudohermaphrodites with 5 alpha-reductase-2 deficiency. J Clin Endocrinol Metab 1994 0.94
18 5 alpha-reductase-2 gene mutations in the Dominican Republic. J Clin Endocrinol Metab 1996 0.92
19 The diagnosis of 5 alpha-reductase deficiency in infancy. J Clin Endocrinol Metab 1986 0.91
20 Primary amenorrhea associated with hirsutism, acanthosis nigricans, dermoid cysts of the ovaries and a new type of insulin resistance. Am J Med 1978 0.90
21 A mutation in the tyrosine kinase domain of the insulin receptor associated with insulin resistance in an obese woman. J Clin Endocrinol Metab 1991 0.90
22 The biochemical and phenotypic characterization of females homozygous for 5 alpha-reductase-2 deficiency. J Clin Endocrinol Metab 1995 0.90
23 Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin. J Clin Endocrinol Metab 1990 0.90
24 Steroid 5 alpha-reductase deficiency in a 65-year-old male pseudohermaphrodite: the natural history, ultrastructure of the testes, and evidence for inherited enzyme heterogeneity. J Clin Endocrinol Metab 1980 0.89
25 Insulin resistance, acanthosis nigricans, and normal insulin receptors in a young woman: evidence for a postreceptor defect. J Clin Endocrinol Metab 1978 0.87
26 Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. N Engl J Med 1997 0.87
27 Proscar: five-year experience. Eur Urol 1995 0.87
28 Increased 5alpha-reductase and normal 11beta-hydroxysteroid dehydrogenase metabolism of C19 and C21 steroids in a young population with polycystic ovarian syndrome. J Pediatr Endocrinol Metab 2000 0.87
29 The development of a male pseudohermaphroditic rat using an inhibitor of the enzyme 5 alpha-reductase. Endocrinology 1985 0.87
30 Urinary steroid metabolites in subjects with male pseudohermaphroditism due to 5 alpha-reductase deficiency. Clin Endocrinol (Oxf) 1985 0.86
31 Male pseudohermaphroditism due to primary 5 alpha-reductase deficiency: variation in gender identity reversal in seven Mexican patients from five different pedigrees. J Endocrinol Invest 1995 0.86
32 Natural potent androgens: lessons from human genetic models. Baillieres Clin Endocrinol Metab 1998 0.85
33 A novel mutation of the human luteinizing hormone receptor in 46XY and 46XX sisters. J Clin Endocrinol Metab 1998 0.84
34 The identification of 5 alpha-reductase-2 and 17 beta-hydroxysteroid dehydrogenase-3 gene defects in male pseudohermaphrodites from a Turkish kindred. J Clin Endocrinol Metab 1998 0.84
35 Nipple differentiation in fetal male rats treated with an inhibitor of the enzyme 5 alpha-reductase: definition of a selective role for dihydrotestosterone. Endocrinology 1986 0.84
36 Studies of the hormonal control of postnatal testicular descent in the rat. J Urol 1993 0.84
37 Decreased urinary C19 and C21 steroid 5 alpha-metabolites in parents of male pseudohermaphrodites with 5 alpha-reductase deficiency: detection of carriers. J Clin Endocrinol Metab 1985 0.82
38 Male pseudohermaphroditism secondary to 17 beta-hydroxysteroid dehydrogenase deficiency: gender role change with puberty. J Clin Endocrinol Metab 1979 0.81
39 5 alpha-reductase activity and prostate cancer: a case-control study using stored sera. Cancer Epidemiol Biomarkers Prev 1997 0.81
40 Luteinizing hormone pulsatility in subjects with 5-alpha-reductase deficiency and decreased dihydrotestosterone production. J Clin Endocrinol Metab 1994 0.80
41 Study of a kindred with classic congenital adrenal hyperplasia: diagnostic challenge due to phenotypic variance. J Clin Endocrinol Metab 1998 0.79
42 Steroid 5alpha-reductase deficiency in man. An inherited form of male pseudohermaphroditism. Birth Defects Orig Artic Ser 1975 0.79
43 Mutations of the 5 alpha-reductase type 2 gene in eight Mexican patients from six different pedigrees with 5 alpha-reductase-2 deficiency. Clin Endocrinol (Oxf) 1997 0.78
44 Decreased 3 alpha-androstanediol glucuronide levels in plasma and random urines in male pseudohermaphroditism caused by 5 alpha-reductase deficiency. Metabolism 1989 0.77
45 Molecular analysis of estrogen induction of preproenkephalin gene expression and its modulation by thyroid hormones. Brain Res Mol Brain Res 2001 0.77
46 Steroid hormone secretion from a virilizing lipoid cell tumor of the ovary. Obstet Gynecol 1981 0.77
47 The prevalence of 5 alpha-reductase deficiency in children with ambiguous genitalia in the Dominican Republic. J Urol 1986 0.76
48 Male pseudohermaphroditism secondary to an abnormality in Leydig cell differentiation. J Clin Endocrinol Metab 1981 0.76
49 Hormonal effects, tolerability, and preliminary kinetics in men of MK-906, a 5 alpha-reductase inhibitor. Steroids 1991 0.75
50 A novel mutation in the CAG triplet region of exon 1 of androgen receptor gene causes complete androgen insensitivity syndrome in a large kindred. J Clin Endocrinol Metab 1999 0.75
51 Cortisol metabolism in the perinatal period. Prog Clin Biol Res 1976 0.75
52 Testosterone secreting adrenal cortical adenomas. Int J Gynaecol Obstet 1981 0.75
53 Late-onset 21-hydroxylase deficiency: reliable diagnosis by steroid analysis of random urine collections. Steroids 1988 0.75
54 Remission of Cushing's syndrome during pregnancy. Int J Gynaecol Obstet 1983 0.75